Most importantly, although we could not entirely exclude the possibility that FGF23 has direct effects on renal tubular cells and/or neutrophils to ameliorate AKI at this moment, at least our data provide convincing evidence that EPCs play a critical role in the response to FGF23 treatment in in vivo and vitro models. This evidence concerns the gene FGF23 and acute kidney injury.